Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic
Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read moreA new Oxford-GSK Institute of Molecular and Computational Medicine will be established through a substantial five-year cooperation between GlaxoSmithKline plc
Read moreGerman multinational science and technology company Merck KGaA announced its Life Science unit, which supplies tools and materials for the
Read moreSCIEX and Evosep have established a collaboration to co-market solutions designed to enhance the stability of high-throughput proteomics systems for
Read moreThe first two projects funded within the translational BRIDGE beLAB1407 collaboration will focus on new mechanisms to treat cancer, Evotec
Read moreScientists from EUCODIS Bioscience, now acquired by and operating under the Biosynth brand, have contributed to new findings on structural
Read moreThe Rosalind Franklin Institute, a new research institute dedicated to developing novel technologies to tackle important health research challenges has
Read moreBoehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read moreHistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read morePharma giant Sanofi will spend €400 million annually towards a vaccines mRNA Center of Excellence, which will be the first
Read more